Hercules Capital Provides $115MM Loan Facility to X4 Pharmaceuticals
X4 Pharmaceuticals, a provider and developer of novel small-molecule therapeutics to benefit people with rare diseases of the immune system, closed a $115 million loan facility with Hercules Capital. The company also announced that it drew down $22.5 million upon the transaction’s closing.
August 4, 2023
Adam Mostafa | Bryan Jadot | Hercules Capital | X4 Pharmaceuticals
Ian Koplin